Lisa M. Schwartz - Publications, H-index & Citations

Lisa M. Schwartz

Massachusetts General Hospital

63H指数

249论文数

1.5W被引数

收录论文 46

发表时间

Randomized Study of Providing Evidence Context to Mitigate Physician Misinterpretation Arising From Off-Label Drug Promotion

CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES

IF6.7

2019-11-01

OAAI

Schwartz, Lisa M.; Woloshin, Steven; Lu, Zhigang; Ross, Kathryn M.; Tessema, Frazer A.; Peter, Doris; Kesselheim, Aaron S.

Visual Representations of Risk Enhance Long-Term Retention of Risk Information: A Randomized Trial

MEDICAL DECISION MAKING

IF2.3

2019-01-11

OAAI

Arrick, Bradley A.; Bloch, Katarzyna J.; Colello, Laura Stein; Woloshin, Steven; Schwartz, Lisa M.

Timeliness of Postmarket Studies for New Pharmaceuticals Approved Between 2009 and 2012: a Cross-Sectional Analysis

JOURNAL OF GENERAL INTERNAL MEDICINE

IF4.2

2018-12-12

OAAI

Wallach, Joshua D.; Egilman, Alexander C.; Ross, Joseph S.; Woloshin, Steven; Schwartz, Lisa M.

Internal Medicine Physicians' Financial Relationships with Industry: An Updated National Estimate

JOURNAL OF GENERAL INTERNAL MEDICINE

IF4.2

2018-10-05

OAAI

Kesselheim, Aaron S.; Woloshin, Steven; Lu, Zhigang; Tessema, Frazer A.; Ross, Kathryn M.; Schwartz, Lisa M.

Focusing on overdiagnosis as a driver of too much medicine

BMJ-BRITISH MEDICAL JOURNAL

IF42.7

2018-08-17

OAAI

Brodersen, John; Kramer, Barnett S.; Macdonald, Helen; Schwartz, Lisa M.; Woloshin, Steven

How Do Women View Risk-Based Mammography Screening? A Qualitative Study

JOURNAL OF GENERAL INTERNAL MEDICINE

IF4.2

2018-07-31

OAAI

He, Xiaofei; Schifferdecker, Karen E.; Ozanne, Elissa M.; Tosteson, Anna N. A.; Woloshin, Steven; Schwartz, Lisa M.

Postmarket studies required by the US Food and Drug Administration for new drugs and biologics approved between 2009 and 2012: cross sectional analysis

BMJ-BRITISH MEDICAL JOURNAL

IF42.7

2018-05-24

OAAI

Wallach, Joshua D.; Egilman, Alexander C.; Dhruva, Sanket S.; McCarthy, Margaret E.; Miller, Jennifer E.; Woloshin, Steven; Schwartz, Lisa M.; Ross, Joseph S.

Characteristics of Interim Publications of Randomized Clinical Trials and Comparison With Final Publications

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

IF55

2018-01-23

OAAI

Woloshin, Steven; Schwartz, Lisa M.; Bagley, Pamela J.; Blunt, Heather B.; White, Brian

The Fate of FDA Postapproval Studies

NEW ENGLAND JOURNAL OF MEDICINE

IF78.5

2017-09-21

PREAI

Woloshin, Steven; Schwartz, Lisa M.; White, Brian; Moore, Thomas J.

Clinical Equipoise and Shared Decision-making in Pulmonary Nodule Management A Survey of American Thoracic Society Clinicians

ANNALS OF THE AMERICAN THORACIC SOCIETY

IF5.4

2017-06-01

OAAI

Iaccarino, Jonathan M.; Simmons, James; Gould, Michael K.; Slatore, Christopher G.; Woloshin, Steven; Schwartz, Lisa M.; Wiener, Renda Soylemez

Media Coverage of FDA Drug Safety Communications about Zolpidem: A Quantitative and Qualitative Analysis

JOURNAL OF HEALTH COMMUNICATION

IF2.4

2017-03-24

PREAI

Woloshin, Steve; Schwartz, Lisa M.; Dejene, Sara; Rausch, Paula; Dal Pan, Gerald J.; Zhou, Esther H.; Kesselheim, Aaron S.

ClinicalTrials.gov and Drugs@FDA: A Comparison of Results Reporting for New Drug Approval Trials

ANNALS OF INTERNAL MEDICINE

IF15.2

2016-09-20

OAAI

Schwartz, Lisa M.; Woloshin, Steven; Zheng, Eugene; Tse, Tony; Zarin, Deborah A.

Physicians' Knowledge About FDA Approval Standards and Perceptions of the Breakthrough Therapy Designation

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

IF55

2016-04-12

OAAI

Kesselheim, Aaron S.; Woloshin, Steven; Eddings, Wesley; Franklin, Jessica M.; Ross, Kathryn M.; Schwartz, Lisa M.

Methodological Approaches to Evaluate the Impact of FDA Drug Safety Communications (vol 38, pg 565, 2015)

DRUG SAFETY

IF3.8

2015-07-23

OAAI

Kesselheim, Aaron S.; Campbell, Eric G.; Schneeweiss, Sebastian; Rausch, Paula; Lappin, Brian M.; Zhou, Esther H.; Seeger, John D.; Brownstein, John S.; Woloshin, Steven; Schwartz, Lisa M.; Toomey, Timothy; Dal Pan, Gerald J.; Avorn, Jerry

Methodological Approaches to Evaluate the Impact of FDA Drug Safety Communications

DRUG SAFETY

IF3.8

2015-05-13

PREAI

Attitudes about Low-Dose Computed Tomography Screening for Lung Cancer: A Survey of American Thoracic Society Clinicians 关于低剂量计算机断层扫描筛查肺癌的态度: 美国胸科学会临床医生的调查

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

IF19.4

2015-02-15

OAAI

Simmons, James; Gould, Michael K.; Woloshin, Steven; Schwartz, Lisa M.; Wiener, Renda Soylemez

WHEN A TEST IS TOO GOOD Authors' reply to Quantrill, Benger, Ripley and colleagues, Roach, Rogers, and Haldar and colleagues